Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Empagliflozin”

420 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 420 results

Post-approval studies (Phase 4)Study completedNCT02932436
What this trial is testing

Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Type 2 Diabetics

Who this might be right for
Diabetes Mellitus, Type 2Diastolic Dysfunction
Johannes Gutenberg University Mainz 144
Post-approval studies (Phase 4)UnknownNCT05200793
What this trial is testing

Efficacy of Empagliflozin or Linagliptin as an Alternative to Metformin for Treatment of Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary Syndrome (PCOS)
Alexandria University 75
Not applicableUnknownNCT03131232
What this trial is testing

The Effect of Empagliflozin on Glucose Metabolism, Weight, Blood Pressure and Cardiac Function (NT-proBNP) Should be Investigated

Who this might be right for
Diabetes Mellitus, Type 2
RWTH Aachen University 46
Large-scale testing (Phase 3)Active Not RecruitingNCT07214818
What this trial is testing

SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Mansoura University 75
Testing effectiveness (Phase 2)Study completedNCT04911660
What this trial is testing

Impact of the SGLT2 Inhibitor Empagliflozin on Urinary Supersaturations in Kidney Stone Formers

Who this might be right for
Kidney Stone
Insel Gruppe AG, University Hospital Bern 50
Large-scale testing (Phase 3)Study completedNCT01719003
What this trial is testing

Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Hyperglycemia
Boehringer Ingelheim 1,413
Early research (Phase 1)Study completedNCT02172248
What this trial is testing

Relative Bioavailability BI 10773 and Metformin in Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 16
Early research (Phase 1)Looking for participantsNCT05553938
What this trial is testing

Effects of Acute and Chronic Empagliflozin Heart Failure

Who this might be right for
Heart Failure
Yale University 60
Post-approval studies (Phase 4)Study completedNCT03193684
What this trial is testing

Empagliflozin and Hepatic Glucose Metabolism

Who this might be right for
Hepatic Glucose Metabolism
The University of Texas Health Science Center at San Antonio 72
Early research (Phase 1)Study completedNCT06889350
What this trial is testing

Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Handok Inc. 40
Large-scale testing (Phase 3)Active Not RecruitingNCT06149793
What this trial is testing

SGLT2 Inhibitor Therapy in Cystic Fibrosis-related Diabetes

Who this might be right for
Cystic Fibrosis-related DiabetesCystic Fibrosis
University of Minnesota 8
Very early researchUnknownNCT04203927
What this trial is testing

Effects of Empagliflozin on Cardiac Microvasculature and Insulin Sensitivity in Subjects With Type 2 Diabetes

Who this might be right for
Type2 DiabetesInsulin Sensitivity
University of Virginia 50
Not applicableUnknownNCT04961931
What this trial is testing

Effect of Empagliflozin on Urinary Excretion of Adenosine and Osteocyte Function in Patients With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease stage3
Medical University of Lodz 45
Large-scale testing (Phase 3)Looking for participantsNCT06506422
What this trial is testing

Empagliflozin Reversal of Arterial StiffnEss in Aging

Who this might be right for
AgingArterial Stiffness
University of Missouri-Columbia 80
Large-scale testing (Phase 3)Looking for participantsNCT07064473
What this trial is testing

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Who this might be right for
Diabetes Mellitus, Type 2HypertensionCardiovascular Diseases
Boehringer Ingelheim 11,800
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06012266
What this trial is testing

Repurposing Empagliflozin and Dapagliflozin for Paediatric Heart Failure: Translational Approach and Dose Rationale

Who this might be right for
Heart Failure
Centre Hospitalier Universitaire Vaudois 12
Not applicableStudy completedNCT06287073
What this trial is testing

JARDIANCE® Post Marketing Surveillance in Korean Patients With Chronic Kidney Disease (CKD)

Who this might be right for
Kidney Disease, Chronic
Boehringer Ingelheim 299
Early research (Phase 1)Study completedNCT01451775
What this trial is testing

Investigation of the Effect of Food on the Bioavailability of a 25 mg Empagliflozin Tablet as Well as Assessment of Dose Proportionality Between 10 mg and 25 mg Empagliflozin Tablets Under Fasting Conditions.

Who this might be right for
Healthy
Boehringer Ingelheim 18
Large-scale testing (Phase 3)Study completedNCT03057951
What this trial is testing

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)

Who this might be right for
Heart Failure
Boehringer Ingelheim 5,988
Not applicableStudy completedNCT03764631
What this trial is testing

Post-authorization Safety Study in Type 2 Diabetic Patients in Saudi Arabia Treated With Empagliflozin to Assess the Incidence of Ketoacidosis, Severe Complications of Urinary Tract Infection, Volume Depletion, and Dehydration

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,502
Load More Results